On June 11, WuXi PharmaTech announced in the evening that shareholder Shanghai Yingyi violated its commitment to reduce its shareholding in the company and apologized.
It is reported that from May 14th to June 8th, Shanghai Yingyi reduced its holdings of the company by a total of 17.2497 million shares, accounting for about 0.7% of the company's total share capital of , and the total amount of reduction was 2.894 billion yuan. Before the implementation of this reduction, Shanghai Yingyi failed to comply with the relevant commitments made by it as a proxy voter about the reduction of the company's shares, did not notify the company in advance, and did not disclose the reduction plan through the company 15 trading days in advance. related procedures.
According to the announcement, the main reason given by Shanghai Yingyi for the above-mentioned breach of commitment is that before the reduction of Shanghai Yingyi’s shareholding, ’s shareholding in accounted for 0.8381% of the company’s total share capital, which was less than 1% of the total share capital, and the relevant staff did not realize it. As a proxy voter, Shanghai Yingyi has made a commitment to reduce the company's shares when the company's A shares are listed, and the CSRC's "Several Regulations on Shareholders, Directors, Supervisors and Senior Management of Listed Companies on Reducing Shares" and "Shanghai Securities Exchange" should apply. Shareholders, directors, supervisors and senior management of the listed company implement the detailed rules for the reduction of shares held by the listed company, which led to the breach of commitment to reduce shareholdings this time.
announced that after Shanghai Yingyi’s self-inspection and confirmation of the above-mentioned violation of commitments, it has immediately stopped the reduction of holdings, and has ordered relevant personnel to reconsolidate and study relevant laws, regulations and normative documents as well as the actions made by Shanghai Yingyi. All commitments, and strictly implement the procedures for pre-reporting and pre-disclosure of the shareholding reduction plan to prevent such incidents from happening again.
As of today's closing , WuXi PharmaTech fell 2.52% to 146.02 yuan.
